eXoZymes, Inc.
EXOZ
$6.17
-$0.14-2.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.75% | 25.31% | 47.90% | 78.68% | 97.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.45% | 47.69% | 63.79% | 82.53% | 117.97% |
| Operating Income | -30.45% | -47.69% | -63.79% | -82.50% | -117.93% |
| Income Before Tax | -33.52% | -45.73% | -58.05% | -64.22% | -95.53% |
| Income Tax Expenses | -4,909.52% | -- | -- | -104.73% | -104.73% |
| Earnings from Continuing Operations | -32.19% | -44.17% | -56.25% | -62.76% | -93.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.19% | -44.17% | -56.25% | -62.76% | -93.30% |
| EBIT | -30.45% | -47.69% | -63.79% | -82.50% | -117.93% |
| EBITDA | -31.32% | -49.43% | -66.44% | -86.57% | -124.92% |
| EPS Basic | -18.58% | -21.25% | -22.94% | -24.57% | -58.80% |
| Normalized Basic EPS | -19.74% | -22.55% | -24.36% | -25.72% | -60.69% |
| EPS Diluted | -18.58% | -21.25% | -22.94% | -24.57% | -58.80% |
| Normalized Diluted EPS | -19.74% | -22.55% | -24.36% | -25.72% | -60.69% |
| Average Basic Shares Outstanding | 11.16% | 18.49% | 27.70% | 30.51% | 21.98% |
| Average Diluted Shares Outstanding | 11.16% | 18.49% | 27.70% | 30.51% | 21.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |